Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze pilot study to improve red blood cell transfusion recovery in autoimmune hemolytic anemia
NL-OMON22958Recruiting
- Sponsor
- Academic Medical Center
- Start
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of c1-esterase inhibitor in autoimmune haemolytic anaemia (AIHA), sponsored by Academic Medical Center. Primary endpoints: Improvement of recovery of red blood cell transfusion, Inhibition of complement activation and deposition on red blood cells via the classical pathway and 1 more. Started Oct 2012; status: recruiting.
02
Drugs
c1-esterase inhibitor
03
Conditions
autoimmune haemolytic anaemia (AIHA)
Beyond the preview
Go deeper on NL-OMON22958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22958.